Pulse Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2024 | 0 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2024 | 0 | -$0.24 | -$0.24 | -$0.24 |
| Q4 2024 | 0 | -$0.24 | -$0.24 | -$0.24 |
Pulse Biosciences, Inc. Earnings Date And Information
Pulse Biosciences, Inc. last posted its earnings results on Thursday, August 10th, 2023. The company reported $-0.19 earnings per share for the quarter, topping analysts' consensus estimates of $-0.22 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Pulse Biosciences, Inc. has generated $-1 earnings per share over the last year ($-0.88 diluted earnings per share) and currently has a price-to-earnings ratio of -22.35. Pulse Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Pulse Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/19/2024 | Q2 2024 | -$0.20 | $0 | $0 | ||
| 05/07/2024 | Q1 2024 | -$0.18 | $0 | $0 | ||
| 03/28/2024 | Q4 2023 | -$0.22 | $0 | $1.74 M | ||
| 11/13/2023 | Q3 2023 | -$0.19 | $0 | $0 | ||
| 08/10/2023 | Q2 2023 | -$0.22 | -$0.22 | 0 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.22 | -$0.27 | -0.05 | $0 | |
| 03/31/2023 | Q4 2022 | -$0.25 | $-9,000 | |||
| 11/10/2022 | Q3 2022 | -$0.45 | -$0.49 | -0.04 | $200,000 | $0 |
| 08/10/2022 | Q2 2022 | -$0.37 | -$0.44 | -0.07 | $265,000 | |
| 05/11/2022 | Q1 2022 | -$0.51 | -$0.58 | -0.07 | $444,000 | |
| 03/31/2022 | Q4 2021 | -$0.50 | -$0.52 | -0.02 | $844,000 | |
| 11/15/2021 | Q3 2021 | -$0.54 | -$0.48 | 0.06 | $188,667 | $574,000 |
| 08/09/2021 | Q2 2021 | -$0.79 | -$0.58 | 0.21 | $34,133 | $0 |
| 05/10/2021 | Q1 2021 | -$0.52 | -$0.71 | -0.19 | $0 | |
| 03/12/2021 | Q4 2020 | -$0.54 | $0 | |||
| 11/09/2020 | Q3 2020 | -$0.44 | -$0.51 | -0.07 | $0 | |
| 08/10/2020 | Q2 2020 | -$0.50 | -$0.53 | -0.03 | $0 | |
| 05/11/2020 | Q1 2020 | -$0.47 | -$0.57 | -0.1 | $0 | |
| 03/16/2020 | Q4 2019 | -$0.61 | -$0.66 | -0.05 | $0 | |
| 11/07/2019 | Q3 2019 | -$0.61 | -$0.57 | 0.04 | $0 |
Pulse Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Pulse Biosciences, Inc.'s earnings date?
Pulse Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
Did Pulse Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Pulse Biosciences, Inc. (:PLSE) reported $-0.19 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.22 by $0.03.
-
How can I listen to Pulse Biosciences, Inc.'s earnings conference call?
The conference call for Pulse Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Pulse Biosciences, Inc.'s conference call transcript?
The conference call transcript for Pulse Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Pulse Biosciences, Inc. generate each year?
Pulse Biosciences, Inc. (:PLSE) has a recorded net income of $0. Pulse Biosciences, Inc. has generated $-0.88 earnings per share over the last four quarters.
-
What is Pulse Biosciences, Inc.'s price-to-earnings ratio?
Pulse Biosciences, Inc. (:PLSE) has a price-to-earnings ratio of -22.35 and price/earnings-to-growth ratio is -0.45.
